109 related articles for article (PubMed ID: 12575227)
1. [Transforming growth factor-beta 1 expression in epithelial ovarian neoplasms and its clinical significance].
Huang XY; Wu YL; Liu FY
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):26-8. PubMed ID: 12575227
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
4. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
5. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
Kuwata T; Kitagawa M; Takemura T; Hirokawa K
Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.
Gordinier ME; Zhang HZ; Patenia R; Levy LB; Atkinson EN; Nash MA; Katz RL; Platsoucas CD; Freedman RS
Clin Cancer Res; 1999 Sep; 5(9):2498-505. PubMed ID: 10499625
[TBL] [Abstract][Full Text] [Related]
8. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
Qiao YH; Cheng J; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
[TBL] [Abstract][Full Text] [Related]
9. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma].
Jin X; Li J; Li Z; Li Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of basic fibroblast growth factor in ovarian epithelial neoplasm].
Lin W; Peng ZL
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):299-304. PubMed ID: 12080823
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
Hu YQ; Liu YJ
Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
Cardillo MR; Yap E; Castagna G
J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
[TBL] [Abstract][Full Text] [Related]
13. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
16. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
Shi HR; Song WJ; Chen ZM; Wu QH
Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
[TBL] [Abstract][Full Text] [Related]
18. Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis.
Yang Y; Hou Y; Wang CL; Ji SJ
Urology; 2006 Apr; 67(4):817-21; discussion 821-2. PubMed ID: 16618565
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
Lu Y; Wu LQ; Li CS; Wang SG; Han B
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
[TBL] [Abstract][Full Text] [Related]
20. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
Sayer RA; Lancaster JM; Pittman J; Gray J; Whitaker R; Marks JR; Berchuck A
Gynecol Oncol; 2005 Feb; 96(2):355-61. PubMed ID: 15661221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
